Table 3.

Overall survival and progression-free survival by average monthly SMI decrease during AAP therapy.

Parameter	SMI loss > 1% per month (N = 12)	Others (N = 31)
PFS events (N)	7 (58.3%)	21 (67.7%)
OS events (N)	2 (16.7%)	10 (32.3%)
PFS (months)
Mean (SD)	16.25 (14.95)	21.11 (17.87)
Median	9.37	15.64
Min-max	3.80–57.12	3.11–82.84
OS (months)
Mean (SD)	23.57 (14.03)	30.02 (19.23)
Median	23.40	24.53
Min-max	7.74–57.12	8.63–87.04

Abbreviations: OS, overall survival; PFS, progression-free survival; SD, standard deviation; SMI, skeletal muscle index.